D.R. Camidge
Impact in
-
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
- Brain Metastases and Treatment
Papers in
-
- Lung Cancer Treatments and Mutations 4
- Oncology 3
- Cancer Immunotherapy and Biomarkers 2
- Cancer Treatment and Pharmacology 1
- Co-authors
- Benjamin Solomon (2 shared papers)G.J. Riely (1 shared paper)Jeffrey William Clark (1 shared paper)Tiziana Usari (1 shared paper)Stewart C. Wang (1 shared paper)Marileila Varella‐Garcia (1 shared paper)Geoffrey Ira Shapiro (1 shared paper)Keith D. Wilner (1 shared paper)
- Journals
- Annals of Oncology (2 papers)Journal of Thoracic Oncology (2 papers)ESMO Open (1 paper)Immuno-Oncology Technology (1 paper)
- Partner nations
- United StatesCanadaSpain
In The Last Decade
D.R. Camidge
4 papers receiving 445 citations
D.R. Camidge's Hit Papers
Peers
Comparison fields: 5 of 39
- Pulmonary and Respiratory Medicine 362
- Drug Discovery 1
- Cancer Research 32
- Oncology 33
- Economics and Econometrics 16
Countries citing papers authored by D.R. Camidge
This map shows the geographic impact of D.R. Camidge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D.R. Camidge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D.R. Camidge more than expected).
Fields of papers citing papers by D.R. Camidge
This network shows the impact of papers produced by D.R. Camidge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D.R. Camidge. The network helps show where D.R. Camidge may publish in the future.
Co-authors
The 25 scholars most cited alongside D.R. Camidge, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Crizotinib in ROS1-rearranged advanced non-small-cell lung cancer (NSCLC): updated results, including overall survival, from PROFILE 1001 Hit paper breakdown → | 2019 | 434 |
| 2 | 2024 | 13 | |
| 3 | 2023 | 5 | |
| 4 | 2022 | 1 | |
| 5 | 2025 | 0 | |
| 6 | 2026 | 0 |
About D.R. Camidge
D.R. Camidge is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Nuclear Energy and Engineering, Waste Management and Disposal and Infectious Diseases, having authored 6 papers that have together received 453 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (4 papers), Cancer Immunotherapy and Biomarkers (2 papers) and Cancer Treatment and Pharmacology (1 paper). The work is most often cited by research in Pulmonary and Respiratory Medicine (362 citations), Drug Discovery (1 citation), Cancer Research (32 citations), Oncology (33 citations) and Economics and Econometrics (16 citations). D.R. Camidge has collaborated with scholars based in United States, Canada and Spain. Frequent co-authors include Benjamin Solomon, G.J. Riely, Jeffrey William Clark, Tiziana Usari, Stewart C. Wang, Marileila Varella‐Garcia, Geoffrey Ira Shapiro, Keith D. Wilner, S.‐H.I. Ou and Anthony John Iafrate. Their work appears in journals such as Annals of Oncology, Journal of Thoracic Oncology, ESMO Open and Immuno-Oncology Technology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.